CIZ Market cap is undervalued20 Dec 2021 11:23
Market cap £7 million is too low
*Cash last call £1.43m. (I estimate around 900k left and given very low burn rate this should take us to end of 2022)
*SGSC : UK commercial deal (amount incoming unknown) and royalty deal (up to £5m.)
*CHINA: (MoU) with 2 partners for the development, supply and commercialisation ( supply and royalties being negotiated)
* FairJourney: collaboration deal with FairJourney Biologics (FJB) for the development and supply (being negotiated)
* Grants, rebates, credits, etc to come
* more deals, partnerships and collaborations to come all adding value.
When we consider the one off costs now done, the low burn rate, the news flow, the deals, existing partnerships and new ones, China and huge potential the products have then then current cap is very cheap.